APAC-based biotech companies in Singapore, South Korea and Japan may offer investors the stability and innovation they are searching for.

The Gates Foundation has announced an investment of $2.5bn to 2030, dedicated to expediting R&D with a focus on improving women's health.

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the US and the EU.